IL147254A0 - Vitamin d3 analogs - Google Patents

Vitamin d3 analogs

Info

Publication number
IL147254A0
IL147254A0 IL14725400A IL14725400A IL147254A0 IL 147254 A0 IL147254 A0 IL 147254A0 IL 14725400 A IL14725400 A IL 14725400A IL 14725400 A IL14725400 A IL 14725400A IL 147254 A0 IL147254 A0 IL 147254A0
Authority
IL
Israel
Prior art keywords
analogs
vitamin
Prior art date
Application number
IL14725400A
Other languages
English (en)
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of IL147254A0 publication Critical patent/IL147254A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C401/00Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/08Drugs for disorders of the urinary system of the prostate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/10Anti-acne agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/24Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/28Antiandrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Urology & Nephrology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL14725400A 1999-07-12 2000-07-06 Vitamin d3 analogs IL147254A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14341399P 1999-07-12 1999-07-12
PCT/EP2000/006393 WO2001004089A1 (en) 1999-07-12 2000-07-06 Vitamin d3 analogs

Publications (1)

Publication Number Publication Date
IL147254A0 true IL147254A0 (en) 2002-08-14

Family

ID=22503954

Family Applications (2)

Application Number Title Priority Date Filing Date
IL14725400A IL147254A0 (en) 1999-07-12 2000-07-06 Vitamin d3 analogs
IL147254A IL147254A (en) 1999-07-12 2001-12-23 Analogs of Vitamin D3

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL147254A IL147254A (en) 1999-07-12 2001-12-23 Analogs of Vitamin D3

Country Status (36)

Country Link
US (1) US6331642B1 (pl)
EP (1) EP1200399B1 (pl)
JP (1) JP3803579B2 (pl)
KR (1) KR100477161B1 (pl)
CN (1) CN1174964C (pl)
AR (1) AR024695A1 (pl)
AT (1) ATE262508T1 (pl)
AU (1) AU779408B2 (pl)
BR (1) BR0012419A (pl)
CA (1) CA2378803C (pl)
CO (1) CO5190683A1 (pl)
DE (1) DE60009303T2 (pl)
DK (1) DK1200399T3 (pl)
EG (1) EG23909A (pl)
ES (1) ES2215707T3 (pl)
GC (1) GC0000198A (pl)
HK (1) HK1047578B (pl)
HR (1) HRP20020007A2 (pl)
HU (1) HUP0202157A3 (pl)
IL (2) IL147254A0 (pl)
JO (1) JO2255B1 (pl)
MA (1) MA26808A1 (pl)
MX (1) MXPA02000313A (pl)
MY (1) MY122633A (pl)
NO (1) NO20020161D0 (pl)
NZ (1) NZ516339A (pl)
PE (1) PE20010328A1 (pl)
PL (1) PL201877B1 (pl)
PT (1) PT1200399E (pl)
RS (1) RS50229B (pl)
RU (1) RU2235721C2 (pl)
TR (1) TR200200054T2 (pl)
TW (1) TWI268276B (pl)
UY (1) UY26239A1 (pl)
WO (1) WO2001004089A1 (pl)
ZA (1) ZA200110487B (pl)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001278744A1 (en) * 2000-08-17 2002-02-25 Chugai Seiyaku Kabushiki Kaisha Remedial agent for osteoporosis
EP1330459B1 (en) 2000-10-02 2006-08-02 Emory University Triptolide analogs for the treatment of autoimmune and inflammatory disorders
RU2296121C2 (ru) * 2001-09-21 2007-03-27 Ф.Хоффманн-Ля Рош Аг Соединения, способ их получения, способы лечения
US8034831B2 (en) 2002-11-06 2011-10-11 Celgene Corporation Methods for the treatment and management of myeloproliferative diseases using 4-(amino)-2-(2,6-Dioxo(3-piperidyl)-isoindoline-1,3-dione in combination with other therapies
US7563810B2 (en) 2002-11-06 2009-07-21 Celgene Corporation Methods of using 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione for the treatment and management of myeloproliferative diseases
EP1622455A4 (en) * 2003-04-30 2009-12-16 Bioxell Spa GEMINI VITAMIN D3 COMPOUNDS AND METHOD FOR THEIR USE
US20050113348A1 (en) * 2003-06-12 2005-05-26 Yanchun Li Vitamin D and vitamin D analogs or derivatives as new anti-hypertensive agents
CA2476224A1 (en) * 2003-09-24 2005-03-24 Bioxell Spa Compound and use in treatment
GB2407499B (en) * 2003-11-03 2008-02-27 Bioxell Spa Vitamin D3 analogue for use in the treatment of BPH
JP2007506780A (ja) * 2003-09-24 2007-03-22 ビオエクセル エスピーエー 膀胱機能障害の治療方法
US8404667B2 (en) * 2006-12-29 2013-03-26 Wisconsin Alumni Research Foundation Compounds, compositions, kits and methods of use to orally and topically treat acne and other skin conditions by 19-Nor vitamin D analog
JP2008514621A (ja) * 2004-09-24 2008-05-08 ビオクセル エッセ ピ ア 20−シクロアルキル,26,27−アルキル/ハロアルキル−ビタミンd3化合物及びその使用方法
AU2005303773A1 (en) 2004-11-12 2006-05-18 Bioxell Spa Combined use of vitamin D derivatives and anti-proliferative agents for treating bladder cancer
US20100009949A1 (en) * 2006-03-24 2010-01-14 Bioxell S.P.A. Novel method
ES2544819T3 (es) * 2007-05-30 2015-09-04 Opko IP Holdings II, Inc. Proceso para la producción de precursores de la vitamina D de óxido de fosfina
CN103251948A (zh) 2008-04-11 2013-08-21 中外制药株式会社 与多个分子的抗原反复结合的抗原结合分子
EP2682386B1 (en) * 2011-03-02 2016-08-17 Nihon University Novel vitamin d receptor modulator with partial agonist activity
KR102523660B1 (ko) 2016-09-26 2023-04-19 (주)하이플 박스용 테두리 부재보강부재와 에셈블리컨테이너 원터치크립이 포함된 박스

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4749710A (en) 1985-05-01 1988-06-07 Hoffmann-La Roche Inc. Immunosuppressive agents
ZA8923B (en) * 1988-01-20 1989-09-27 Hoffmann La Roche 16-dehydro-vitamin d3-derivatives
US5087619A (en) * 1988-01-20 1992-02-11 Hoffman-La Roche Inc. Vitamin D3 analogs
CA2096105A1 (en) * 1992-10-07 1994-04-08 Enrico Giuseppe Baggiolini (Deceased) Vitamin d3 fluorinated analogs
US5401733A (en) * 1993-10-01 1995-03-28 Hoffmann-La Roche Inc. Stable and active metabolites of 1,25-dihydroxy-16-ene-cholecalciferol
US5428029A (en) * 1993-11-24 1995-06-27 Hoffmann-La Roche Inc. Vitamin D3 fluorinated analogs
US6040300A (en) * 1995-04-07 2000-03-21 Arch Development Corporation Method of preventing colon cancer with vitamin D3 analogues
AU708679B2 (en) 1996-03-21 1999-08-12 F. Hoffmann-La Roche Ag 1,25-dihydroxy-16,22,23-trisdehydro-cholecalciferol derivatives

Also Published As

Publication number Publication date
EP1200399A1 (en) 2002-05-02
BR0012419A (pt) 2002-03-26
HK1047578A1 (en) 2003-02-28
NO20020161L (no) 2002-01-11
MXPA02000313A (es) 2002-06-21
JO2255B1 (en) 2004-10-07
UY26239A1 (es) 2000-10-31
PE20010328A1 (es) 2001-03-22
JP2003504354A (ja) 2003-02-04
PL356124A1 (pl) 2004-06-14
CA2378803C (en) 2009-01-27
PT1200399E (pt) 2004-06-30
AR024695A1 (es) 2002-10-23
DK1200399T3 (da) 2004-07-19
EG23909A (en) 2007-12-30
TR200200054T2 (tr) 2002-06-21
HUP0202157A2 (en) 2002-10-28
HRP20020007A2 (en) 2003-04-30
CN1360572A (zh) 2002-07-24
KR20020033728A (ko) 2002-05-07
MY122633A (en) 2006-04-29
AU779408B2 (en) 2005-01-20
EP1200399B1 (en) 2004-03-24
NO20020161D0 (no) 2002-01-11
HUP0202157A3 (en) 2004-04-28
RU2235721C2 (ru) 2004-09-10
TWI268276B (en) 2006-12-11
ZA200110487B (en) 2003-03-20
ATE262508T1 (de) 2004-04-15
DE60009303D1 (de) 2004-04-29
KR100477161B1 (ko) 2005-03-18
ES2215707T3 (es) 2004-10-16
DE60009303T2 (de) 2005-02-24
RS50229B (sr) 2009-07-15
YU92701A (sh) 2004-09-03
CO5190683A1 (es) 2002-08-29
IL147254A (en) 2006-07-05
NZ516339A (en) 2003-07-25
WO2001004089A1 (en) 2001-01-18
US6331642B1 (en) 2001-12-18
CA2378803A1 (en) 2001-01-18
GC0000198A (en) 2006-03-29
JP3803579B2 (ja) 2006-08-02
CN1174964C (zh) 2004-11-10
AU6689400A (en) 2001-01-30
HK1047578B (zh) 2005-04-29
PL201877B1 (pl) 2009-05-29
MA26808A1 (fr) 2004-12-20

Similar Documents

Publication Publication Date Title
PL347548A1 (en) Vitamin d analogues
IL153378A0 (en) STABILIZED 1alpha-HYDROXY VITAMIN D
GB9914222D0 (en) Pharmeceutical compounds
SG85223A1 (en) Elevator
PL364768A1 (pl) Analogi witaminy D
HK1040690A1 (en) Elevator arrangement
SG70009A1 (en) Vitamin d3 analogs
GC0000198A (en) Vitamin d3 analogs
GB9906457D0 (en) Anti-oxidant
PL355432A1 (pl) Analogi witaminy D
EP1174383A4 (en) ESCALATOR
EP1275643A4 (en) DERIVATIVES OF VITAMIN D
AU140483S (en) Outsole
ZA9811460B (en) Novel vitamin d3 derivatives
IL146184A0 (en) Antioxidative vitamin b6 analogs
AU6550800A (en) Hepoxilin analogs
SI1200399T1 (en) Vitamin d3 analogs
PL356301A1 (pl) Nowe analogi witaminy D
GB9916950D0 (en) Walkway
AU2337801A (en) Angiopoietin analogs
GB9905498D0 (en) Expression
TW520740U (en) Escalator
AU2291600A (en) New vitamin d analogs
GB9924096D0 (en) Supplement
GB9907749D0 (en) Elevator

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed